Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW
Malar J 2007, 6:72
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Research    
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Cohen JM, Singh I, O'Brien ME
Malaria Journal 2008, 7:200 (2 October 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.
37%37%


 Research    
Cost of increasing access to artemisinin combination therapy: the Cambodian experience
Yeung S, Van Damme W, Socheat D, White NJ, Mills A
Malaria Journal 2008, 7:84 (20 May 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.
37%37%


 Research    
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Wasunna B, Zurovac D, Goodman CA, Snow RW
Malaria Journal 2008, 7:29 (5 February 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.
37%37%


 Research    
The decline in paediatric malaria admissions on the coast of Kenya
Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, Marsh K, Snow RW
Malaria Journal 2007, 6:151 (15 November 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 4 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.